Cara therapeutics stock price target

Find the latest Cara Therapeutics, Inc. (CARA) stock quote, history, news and other vital information to help you with your stock trading and investing. CARA | Cara Therapeutics Inc. Analyst Estimates & Rating – WSJ

Their average twelve-month price target is $33.80, suggesting that the stock has a possible upside of 169.32%. The high price target for CARA is $39.00 and the  4 analysts have issued 12-month price targets for Cara Therapeutics' shares. Their forecasts range from $30.00 to $39.00. On average, they anticipate Cara  Find the latest analyst research for Cara Therapeutics, Inc. Common Stock ( CARA) at Nasdaq.com. Analyst price targets provided by TipRanks. At $85.83, the average price target implies 50% upside potential. (See MyoKardia stock analysis on TipRanks)Cara Therapeutics (CARA)By developing a class  CARA | Complete Cara Therapeutics Inc. stock news by MarketWatch. View real- time stock prices and stock quotes for a full financial overview. products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. Cara Therapeutics Inc. analyst estimates by MarketWatch. View CARA Average Recommendation: Buy, Average Target Price: 32.11 Earnings Per Share  Cara Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CARA updated stock price target summary.

Cara Therapeutics (NASDAQ:CARA) resumed with Buy rating and $22 (53% upside) price target at H.C. Wainwright.Mirati Therapeutics (NASDAQ:MRTX) initiated with Overweight rating and $44 (27% upside) pri

Stock quote for Cara Therapeutics, Inc. Common Stock Common Stock (CARA) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. CARA THERAPEUTICS, INC. : CARA Stock Price | MarketScreener Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body's Cara Therapeutics - CARA - Stock Price & News | The Motley ...

Company Name: Cara Therapeutics Inc., Stock Symbol: CARA, Industry: Biotechs , Total Analysts' Ratings History for Cara Therapeutics (NASDAQ:CARA) 

Cara Therapeutics, Inc. - CARA - Stock Price Today - Zacks View Cara Therapeutics, Inc. CARA investment & stock information. Get the latest Cara Therapeutics, Inc. CARA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. CARA - Cara Therapeutics Summary, Stock Quote and News ... Jan 01, 2010 · Cara Therapeutics (NASDAQ: CARA) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on CARA - Stock quote for CARA THERAPEUTICS, INC. - MSN Money

CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain.

Could Cara Therapeutics, Inc. Be a Millionaire-Maker Stock ... Could Cara Therapeutics, Inc. Be a Millionaire-Maker Stock? no gain." In Cara Therapeutics And I think with a sizable enough up-front investment and patience to hold on to the stock for CARA Stock Quote - Cara Therapeutics, Inc. Common Stock ... Stock quote for Cara Therapeutics, Inc. Common Stock Common Stock (CARA) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. CARA THERAPEUTICS, INC. : CARA Stock Price | MarketScreener

CARA Stock Price & Charts | Cara Therapeutics

NASDAQ | CARA: Cara Therapeutics Stock News, Ratings ... Looking for insights on Cara-therapeutics (NASDAQ:CARA) stock? View CARA's stock ratings, price targets, earnings, commentary and news at Smarter Analyst. Is A Downturn Overdue? Cara Therapeutics Inc. (NASDAQ:CARA ...

Cara Therapeutics, Inc. (CARA) Stock Message Board ... Company Description: Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation.Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. Cara Therapeutics, Inc. - CARA - Stock Price Today - Zacks View Cara Therapeutics, Inc. CARA investment & stock information. Get the latest Cara Therapeutics, Inc. CARA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.